These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18988879)

  • 1. Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?
    Giannini C; Gragnani L; Piluso A; Caini P; Petrarca A; Monti M; Laffi G; Zignego AL
    Blood; 2008 Nov; 112(10):4353-4. PubMed ID: 18988879
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients.
    Ayad MW; Elbanna AA; Elneily DA; Sakr AS
    Mol Diagn Ther; 2015 Apr; 19(2):99-106. PubMed ID: 25800158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors.
    Gragnani L; Piluso A; Giannini C; Caini P; Fognani E; Monti M; Petrarca A; Ranieri J; Razzolini G; Froio V; Laffi G; Zignego AL
    Arthritis Rheum; 2011 May; 63(5):1446-51. PubMed ID: 21538321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor.
    Liao TL; Chen YM; Hsieh SL; Tang KT; Chen DY; Yang YY; Liu HJ; Yang SS
    mBio; 2021 Dec; 12(6):e0276421. PubMed ID: 34724826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's Lymphoma.
    Gragnani L; Lorini S; Marri S; Rattotti S; Madia F; Zibellini S; Monti M; Basile U; Di Stasio E; Libra M; Arcaini L; Zignego AL
    Hematol Oncol; 2022 Oct; 40(4):658-666. PubMed ID: 35460540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus-mixed cryoglobulinemia-lymphoma relationship.
    Nicolau A; Tănăsescu R; Bălănescu E; Bălănescu P; Pătraşcu R; Tănăsescu C
    Rom J Intern Med; 2011; 49(1):3-10. PubMed ID: 22026247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy.
    Saadoun D; Bieche I; Maisonobe T; Asselah T; Laurendeau I; Piette JC; Vidaud M; Cacoub P
    Arthritis Rheum; 2005 Sep; 52(9):2917-25. PubMed ID: 16142759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
    Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
    Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
    Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
    J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mixed cryoglobulinemia and the hepatitis C virus].
    Bulfoni A
    Minerva Med; 1995 May; 86(5):193-8. PubMed ID: 7566548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed cryoglobulinemia and hepatitis C virus association: ten years later.
    Della Rossa A; Tavoni A; Baldini C; Bombardieri S
    Isr Med Assoc J; 2001 Jun; 3(6):430-4. PubMed ID: 11433637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.
    Emmerich F; Bal G; Barakat A; Milz J; Mühle C; Martinez-Gamboa L; Dörner T; Salama A
    Br J Haematol; 2007 Jan; 136(2):309-14. PubMed ID: 17156395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell activating factor promoter polymorphisms in egyptian patients with systemic lupus erythematosus.
    Zayed RA; Sheba HF; Abo Elazaem MA; Elsaadany ZA; Elmessery LO; Mahmoud JA; Abdel Rahman DR; Abdou FR
    Ann Clin Lab Sci; 2013; 43(3):289-94. PubMed ID: 23884224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis C and immunoglobulin heavy-chain gene rearrangement].
    Gasztonyi B; Pár A; Kereskai L; Pajor L; Kiss K; Szeberényi J; Mózsik G
    Orv Hetil; 2002 Apr; 143(15):767-70. PubMed ID: 11979995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases.
    Zignego AL; Giannelli F; Marrocchi ME; Giannini C; Gentilini P; Innocenti F; Ferri C
    Clin Exp Rheumatol; 1997; 15(6):711-2. PubMed ID: 9444437
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.
    Eilertsen GØ; Van Ghelue M; Strand H; Nossent JC
    Rheumatology (Oxford); 2011 Dec; 50(12):2197-205. PubMed ID: 21984763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hepatitis C virus-related mixed cryoglobulinemia.
    Iannuzzella F; Vaglio A; Garini G
    Am J Med; 2010 May; 123(5):400-8. PubMed ID: 20399313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Association Studies and Hepatitis C: Harvesting the Benefits of the Genomic Revolution.
    Eslam M; George J
    Semin Liver Dis; 2015 Nov; 35(4):402-20. PubMed ID: 26676815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocyte stimulator -817C>T promoter polymorphism and the predisposition for the development of deep infiltrating endometriosis.
    de Graaff AA; Dunselman GA; Delvoux B; van Kaam KJ; Smits LJ; Romano A
    Fertil Steril; 2010 Aug; 94(3):1108-10. PubMed ID: 20004378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.
    Rosa D; Saletti G; De Gregorio E; Zorat F; Comar C; D'Oro U; Nuti S; Houghton M; Barnaba V; Pozzato G; Abrignani S
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18544-9. PubMed ID: 16339892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.